Reach Us +441414719275
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Biomolecules and Biochemistry

Sign up for email alert when new content gets added: Sign up

PRPS-1 is a regulative for neuroprotection and cells regenerative proliferation

Author(s): Danielyan KE*, Vardanyan R, Paronyan ZK, Barkhudaryants IM, Chailyan SG and Bisharyan MS

Background: Phosphoribosylpyrophosphate synthetase-1 (PRPS-1; EC 2.7.6.1) is the widely distributed in the human tissues and serves as a regulative key enzyme for purine metabolism, whereas Xanthine Oxidoreductase (XOR; EC 1.1.3.22) is the enzyme responsible for the catabolism of purine nucleotides and might by feed-back mechanism coordinate this entire biochemical pathway. We proposed activation of PRPS-1 and simultaneous inhibition of XOR might initiate regenerative processes after stroke.
Methods: We used hydrogen peroxide intracranial injection (3%) as the model for ROS generation phase of stroke development. XOR activity was measured by evaluation of uric acid formation. PRPS-1 was measured by the kit (Novocib, France). Blood Brain Barrier integrity was evaluated by utility of Evans Blue. KI-67 was used for detection of cells proliferation. ANOVA one-way analysis was used for evaluation of statistical significance of the results. Pearson coefficient was calculated for delineation of the correlation of XOR and PRPS-1 dynamic changes of activities.
Results: PRPS-1 activity after stroke in rats was stimulated by phosphates (control; 1.9145 ± 0.0400 vs phosphates treatment 6.6304 ± 0.0500 vs allopurinol treatment 1.6921 ± 0.0359, p<0.05). In phosphate treated group in comparison with the control XOR activity was lower (control; blank - 0.6406 ± 0.0378; substrate - 0.8513 ± 0.1527; phosphate treatment group blank - 0.2500 ± 7.5758e-3 vs substrate 0.3314 ± 0.0625; allopurinol treated group: blank - 0.5549 ± 8.1301e-3 vs substrate 0.5786 ± 0.017). Ki-67 incorporation was more pronounced in phosphate treated group in comparison with the control. BBB disruption was less in experimental vs control groups.
Conclusion: Phosphates are proposed to be used as the post stroke regenerative agents.


Full-Text | PDF